Source: International Congress 2016 – New findings in mucosal immunology
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Christopher Cole (Middlesbrough, United Kingdom), Christopher Cole, Sonya Carnell, Kasim Jiwa, Jodie Birch, Katy Hester, Chris Ward, John Simpson, Anthony De Soyza. Neutrophil vascular endothelial growth factor (VEGF) as a driving force for angiogenesis in bronchiectasis?. Eur Respir J 2016; 48: Suppl. 60, 1827

Member's Comments

No comment yet.

Related content which might interest you: Vascular endothelial growth factor (VEGF) and airway inflammation in COPD. Correlation with pulmonary function Source: Eur Respir J 2006; 28: Suppl. 50, 653s Year: 2006 Bioavailability of vascular endothelial growth factor (VEGF)? A role in pulmonary fibrosis? Source: Annual Congress 2012 - Fibrogenesis between epithelial injury and fibroblast proliferation Year: 2012 A role for vascular endothelial growth factor (VEGF) in fibrosis? Source: Annual Congress 2009 - From emphysema to fibrosis: mechanisms of cellular remodelling in the diseased lung Year: 2009 Vascular endothelial growth factor (VEGF) and bronchial wall remodelling in asthma Source: Annual Congress 2004 - Genetics and molecular mechanisms of COPD and asthma Year: 2004 The clininical value of vascular endothelial growth factor (VEGF) in the development of lung sarcoidosis. Source: International Congress 2018 – Sarcoidosis: from basic research to patient outcomes Year: 2018 Vascular endothelial growth factor (VEGF) as marker of pulmonary hypertension in children with asthma Source: International Congress 2014 – Pulmonary hypertension in lung disease Year: 2014 Vascular endothelial growth factor (VEGF) , a specific marker of angiogenesis, is increased in asthmatic airways following allergen challenge Source: Eur Respir J 2004; 24: Suppl. 48, 227s Year: 2004 Macrophage migration inhibitory factor (MIF), a biomarker in COPD? Source: International Congress 2014 – New insights into monocyte and macrophage biology Year: 2014 Epidermal growth factor receptor (EGFR) activation is required for TGFbeta1-induced epithelial-mesenchymal transition (EMT) in idiopathic pulmonary fibrosis (IPF) Source: Annual Congress 2013 –Growth factors at the crossroads of acute and chronic inflammation Year: 2013 Imbalance between vascular endothelial growth factor and endostatin in emphysema Source: Eur Respir J 2003 Oct 01;22(4):609-612 Year: 2003 Fibroblast growth factor 9 (FGF9) modulates the phenotype of control and fibrotic human lung fibroblasts in vitro Source: International Congress 2014 – New and old players in fibrotic lung disease Year: 2014 Vascular endothelial growth factor levels in active pulmonary tuberculosis Source: Eur Respir J 2002; 20: Suppl. 38, 610s Year: 2002 Vascular endothelial growth factor (VEGF) is a predictable marker for FEV1 progression in patients with Lymphangiolyomyomatosis (LAM). Source: International Congress 2019 – Innovative approaches for management and treatment of rare diffuse parenchymal lung diseases Year: 2019 MMP expression and abnormal lung permeability are important determinants of outcome in IPF Source: Eur Respir J 2009; 33: 77-84 Year: 2009 Hypoxia inducible factor-1? in human emphysema lung tissue Source: Eur Respir J 2011; 37: 775-783 Year: 2011 Vascular endothelial growth factor (VEGF) levels in induced sputum and plasma in asymptomatic and COPD smokers. Correlation with airway and systemic inflammation Source: Eur Respir J 2006; 28: Suppl. 50, 652s Year: 2006 Expression of macrophage migration inhibitory factor in patients with idiopathic pulmonary fibrosis Source: International Congress 2015 – Interstitial lung diseases II Year: 2015 Circulating and exhaled vascular endothelial growth factor in asthmatic pregnancy Source: Annual Congress 2013 –Assessment of airway inflammation by exhaled gases Year: 2013 Vascular endothelial growth factor modulates matrix metalloproteinase-9 expression in asthma Source: Eur Respir J 2006; 28: Suppl. 50, 444s Year: 2006